首页 | 本学科首页   官方微博 | 高级检索  
     

肺炎衣原体感染与原发性胆汁性肝硬化的相关性研究
引用本文:刘海英,范列英,屠小卿,周晔,陈燕,邓安梅,仲人前. 肺炎衣原体感染与原发性胆汁性肝硬化的相关性研究[J]. 中华肝脏病杂志, 2004, 12(9): 546-548
作者姓名:刘海英  范列英  屠小卿  周晔  陈燕  邓安梅  仲人前
作者单位:200003,上海,第二军医大学长征医院实验诊断科暨全军临床免疫中心
基金项目:国家自然科学基金(30080027),上海市百人计划(沪卫科9713)
摘    要:目的 通过检测原发性胆汁性肝硬化(PBC)患者血清中抗肺炎衣原体(CP)IgG、IgM水平,探讨CP感染与PBC之间的相关性。 方法 采用CP酶联免疫固相吸附试验检测41例PBC患者(PBC组)、70例肝炎后肝硬化(疾病对照组,PHC组)和57名健康查体者(正常对照组)血清抗CP IgG、IgM抗体水平。 结果 PBC组和PHC组的抗CP IgG平均水平(RU/ml)较正常对照组高(46.8±43.4、49.5±45.2与28.3±32.7,P=0.042与P<0.001),但PBC组与PHC组之间差异无显著性(P=O.059);PBC组、PHC组抗CP IgG阳性率亦高于正常对照组(68.3%、71.4%与42.1%,x2值分别为5.389、11.110,P值均小于0.05),PBC组与PHC组差别无显著性(x2=0.378,P>0.05);PBC组患者的血清抗CP IgM阳性率最高(22.0%),明显高于其它两组。与正常对照组比较,PBC组抗CP IgG、IgM阳性的比率比(OR)分别为2.7(95% CI:0.9~6.1)、5.1(95% CI:1.4~18.5);血清抗CP IgG水平与总IgG浓度无相关性(r=-0.857,P=0.344),而抗CP IgM阳性与总IgM异常升高有关。 结论 血清学研究结果尚不能支持肺炎衣原体是PBC的一个始动因素这一观点,但CP感染可能是造成PBC中IgM升高的原因之一。

关 键 词:CP PBC 抗C 对照组 PHC 正常 血清
修稿时间:2003-09-03

The relationship between Chlamydia pneumoniae infection and primary biliary cirrhosis
LIU Hai-ying,FANLie-ying,TU Xiao-qing,ZHOU Ye,CHEN Yan,DENG An-mei,ZHONG Ren-qian. Laboratory Diagnostics,Changzheng Hospital,Second Military Medical University and Clinical Immunology Center of PLA,Shanghai ,China. The relationship between Chlamydia pneumoniae infection and primary biliary cirrhosis[J]. Chinese journal of hepatology, 2004, 12(9): 546-548
Authors:LIU Hai-ying  FANLie-ying  TU Xiao-qing  ZHOU Ye  CHEN Yan  DENG An-mei  ZHONG Ren-qian. Laboratory Diagnostics  Changzheng Hospital  Second Military Medical University  Clinical Immunology Center of PLA  Shanghai   China
Affiliation:Laboratory Diagnostics, Changzheng Hospital, Second Military Medical University and Clinical Immunology Center of PLA, Shanghai 200003, China.
Abstract:OBJECTIVE: The aim of this study was to evaluate the association between Chlamydia pneumoniae (CP) infection and primary biliary cirrhosis (PBC). METHODS: Chlamydia pneumoniae IgG and IgM were determined by enzyme-linked immunosorbent assay (ELISA) in 41 well-established PBC patients and two race-matched control groups, PHC, n = 70; healthy controls, HC, n =57). RESULTS: The mean levels and seroprevalence of CP IgG in PBC group and PHC group were significantly higher than in the HC [(46.8 +/- 43.4) RU/ml, (49.5 +/- 45.2) RU/ml vs (28.3 +/- 32.7) RU/ml, P = 0.042 and P < 0.001 respectively; 68.3%, 71.4% vs 42.1%, chi2 values were 5.389 and 11.110 respectively]. There was a markedly elevated seroprevalence of CP IgM in patients with PBC (22.0%) compared with the PHC and HC groups. The odds ratios (ORs) for the presence of CP IgG and IgM for the PBC patients versus the HC were 2.7 (95% CI 0.9 to 6.1) and 5.1 (95% CI 1.4 to 18.5). Though there was no correlation in the level of CP IgG with total IgG in sera of patients with PBC (r=-0.857, p=0.344), CP IgM was related with the abnormally high concentrations of total IgM in the PBC group. CONCLUSIONS: The results of this study do not support the hypothesis that infection with Chlamydia pneumoniae may be a triggering agent for PBC, but suggest that Chlamydia pneumoniae infection probably contributes to the high level of IgM presented in most of the patients with PBC
Keywords:Liver cirrhosis   biliary  Chlamydia pneumoniae  Antibodies
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号